Publication:
Clinical specimen-Direct LAMP: A useful tool for the surveillance of blaOXA-23-Positive carbapenem-resistant acinetobacter baumannii

dc.contributor.authorNorihisa Yamamotoen_US
dc.contributor.authorShigeto Hamaguchien_US
dc.contributor.authorYukihiro Akedaen_US
dc.contributor.authorPitak Santaniranden_US
dc.contributor.authorAnusak Kerdsinen_US
dc.contributor.authorMasafumi Sekien_US
dc.contributor.authorYoshikazu Ishiien_US
dc.contributor.authorWantana Paveenkittipornen_US
dc.contributor.authorRobert A. Bonomoen_US
dc.contributor.authorKazunori Oishien_US
dc.contributor.authorKumthorn Malathumen_US
dc.contributor.authorKazunori Tomonoen_US
dc.contributor.otherOsaka University Faculty of Medicineen_US
dc.contributor.otherOsaka Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherToho Universityen_US
dc.contributor.otherVA Medical Centeren_US
dc.contributor.otherNational Institute of Infectious Diseasesen_US
dc.date.accessioned2018-11-23T09:30:01Z
dc.date.available2018-11-23T09:30:01Z
dc.date.issued2015-07-28en_US
dc.description.abstract© 2015 Yamamoto et al. Healthcare-associated infections are a leading cause of morbidity and mortality worldwide. Treatment is increasingly complicated by the escalating incidence of antimicrobial resistance. Among drug-resistant pathogens, carbapenem-resistant Acinetobacter baumannii (CRAb) is of increasing concern because of the limited applicable therapies and its expanding global distribution in developed countries and newly industrialized countries. Therefore, a rapid detection method that can be used even in resource-poor countries is urgently required to control this global public health threat. Conventional techniques, such as bacterial culture and polymerase chain reaction (PCR), are insufficient to combat this threat because they are time-consuming and laborious. In this study, we developed a loop-mediated isothermal amplification (LAMP) method for detecting blaOXA-23-positive CRAb, themost prevalent form of CRAb in Asia, especially in Thailand, and confirmed its efficacy as a surveillance tool in a clinical setting. Clinical samples of sputum and rectal swabs were collected from patients in a hospital in Bangkok and used for LAMP assays. After boiling and centrifugation, the supernatants were used directly in the assay. In parallel, a culture method was used for comparison purposes to evaluate the specificity and sensitivity of LAMP. As a first step, a total of 120 sputum samples were collected. The sensitivity of LAMP was 88.6% (39/44), and its specificity was 92.1%(70/76) using the culture method as the "gold standard".When surveillance samples including sputum and rectal swabs were analyzed with the LAMP assay, its sensitivity was 100.0%. This method enables the direct analysis of clinical specimens and provides results within 40minutes of sample collection, making it a useful tool for surveillance even in resource-poor countries. Healthcare-associated infections are a leading cause of morbidity and mortality worldwide. Treatment is increasingly complicated by the escalating incidence of antimicrobial resistance. Among drug-resistant pathogens, carbapenem-resistant Acinetobacter baumannii (CRAb) is of increasing concern because of the limited applicable therapies and its expanding global distribution in developed countries and newly industrialized countries. Therefore, a rapid detection method that can be used even in resource-poor countries is urgently required to control this global public health threat. Conventional techniques, such as bacterial culture and polymerase chain reaction (PCR), are insufficient to combat this threat because they are time-consuming and laborious. In this study, we developed a loop-mediated isothermal amplification (LAMP) method for detecting blaOXA-23-positive CRAb, the most prevalent form of CRAb in Asia, especially in Thailand, and confirmed its efficacy as a surveillance tool in a clinical setting. Clinical samples of sputum and rectal swabs were collected from patients in a hospital in Bangkok and used for LAMP assays. After boiling and centrifugation, the supernatants were used directly in the assay. In parallel, a culture method was used for comparison purposes to evaluate the specificity and sensitivity of LAMP. As a first step, a total of 120 sputum samples were collected. The sensitivity of LAMP was 88.6% (39/44), and its specificity was 92.1% (70/76) using the culture method as the "gold standard". When surveillance samples including sputum and rectal swabs were analyzed with the LAMP assay, its sensitivity was 100.0%. This method enables the direct analysis of clinical specimens and provides results within 40 minutes of sample collection, making it a useful tool for surveillance even in resource-poor countries.en_US
dc.identifier.citationPLoS ONE. Vol.10, No.7 (2015)en_US
dc.identifier.doi10.1371/journal.pone.0133204en_US
dc.identifier.issn19326203en_US
dc.identifier.other2-s2.0-84942062013en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/35128
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942062013&origin=inwarden_US
dc.subjectAgricultural and Biological Sciencesen_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleClinical specimen-Direct LAMP: A useful tool for the surveillance of blaOXA-23-Positive carbapenem-resistant acinetobacter baumanniien_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942062013&origin=inwarden_US

Files

Collections